{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-042513","form_type":"8-K","ticker":"BCLI","cik":"0001137883","company_name":"BRAINSTORM CELL THERAPEUTICS INC.","filed_at":"2024-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.423999+00:00","generated_at":"2026-06-04T03:18:54.203295+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Brainstorm Cell Therapeutics removes Leerink Partners as ATM selling agent","bullets":["Amendment No. 1 to Distribution Agreement dated April 2, 2024 removes Leerink Partners as agent.","Raymond James remains as the sole agent under the existing $100M ATM equity program.","Original Distribution Agreement was entered August 9, 2021; no change to offering size or terms.","Company's common stock trades on Nasdaq under ticker BCLI."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-042513","json":"https://secwatch.observer/filing/0001104659-24-042513.json","markdown":"https://secwatch.observer/filing/0001104659-24-042513.md","text":"https://secwatch.observer/filing/0001104659-24-042513.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924042513/0001104659-24-042513-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924042513/tm2410454d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T03:18:54.203295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a13272e6e51943b9d8aca6997bf45bf96ff230ca","claim":"BRAINSTORM CELL THERAPEUTICS INC. amended Distribution Agreement with Leerink Partners LLC (effective 2024-04-02).","evidence_excerpt":"On April 2, 2024, the Company entered into an amendment No. 1 to the Distribution Agreement (“Amendment No. 1”) pursuant to which Leerink Partners ceased to be an agent under the Distribution Agreement.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465924042513/0001104659-24-042513-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Leerink Partners LLC"},{"label":"Effective","value":"2024-04-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}